Research · Sep 3, 2026
[MC] Moelis & Company Thesis 2026: A Founder-Led Independent Advisory Boutique Rides M&A Cycle Recovery
Moelis & Company (NYSE: MC), headquartered in New York City, is an independent global investment-banking advisory firm providing M&A + Capital Markets + Restructuring/Liability-Management advisory services to corporate + private-equity + creditor + debtor + government customers globally. Founded in 2007 by Ken Moelis (prior UBS Head of Global Investment Banking 2001-2007 + Donaldson Lufkin & Jenrette 1990s-2001 + Drexel Burnham Lambert 1980s) in New York City as Ken-Moelis-led + Senior-Banker-anchored independent-advisory boutique post-financial-crisis-era + selectively-emerging-on-the-2007-2009-era independent-advisory-shift, IPO'd 2014 on NYSE at ~$25/share. Through multi-decade strategic-build-out Moelis built global platform across ~25 office-locations globally (Americas: NYC + Boston + Chicago + Dallas + Houston + LA + SF + DC + Sao Paulo + Mexico City; EMEA: London + Frankfurt + Paris + Amsterdam + Zurich + Madrid + Milan + Dubai + Tel Aviv + Mumbai; Asia-Pacific: Hong Kong + Beijing + Shanghai + Tokyo + Sydney), ~1,000-1,200 total Managing Directors + Senior Bankers providing mid-to-senior banker-density, founder-aligned-equity-compensation (Ken Moelis + Senior-Bankers ~25-35%+ of shares-outstanding), and selectively-distinctive Restructuring-advisory leadership-position alongside Houlihan Lokey + PJT Partners. Under President & CEO Ken Moelis (Founder + CEO + Chairman since 2007, Wall-Street-advisory-and-investment-banking veteran with ~40+ year career), FY2025 closes with selected various aggregate revenue ~$1.0-1.3B (selectively-cyclical M&A-recovery from 2023 trough), adjusted EBITDA-margin ~22-28% (recovering), adjusted EPS ~$2.50-3.85, net cash ~$0.30-0.55B, and ~75M shares outstanding. The first deep-dive — M&A + Capital Markets + Restructuring independent-advisory franchise — covers three-segment advisory-revenue business + multi-decade-Wall-Street-independent-advisory-positioning. M&A advisory (~$0.55-0.80B, ~55-65%) provides buy-side + sell-side strategic-advisory for large + mid-market corporate-transactions globally across strategic-acquisitions + divestitures, mergers + cross-border, corporate-defense + special-committees, and fairness-opinions + strategic-reviews; broad sector-coverage. Capital Markets advisory (~$0.15-0.30B, ~15-25%) provides ECM (IPO-and-follow-on + PIPE + rights-issue), DCM (bond + leveraged-finance + convertible), and private-fund-placement. Restructuring/Liability-Management advisory (~$0.15-0.30B, ~15-25%) provides Chapter 11 + out-of-court restructuring (top-3 global alongside Houlihan Lokey + PJT Partners), creditor + debtor + ad-hoc committee, and liability-management + distressed-M&A (elevated 2023-2025 default-cycle). Independent-advisory positioning competes with Lazard (LAZ largest US-listed + asset-management diversified), Houlihan Lokey (HLI largest restructuring + mid-market), Evercore (EVR large-cap-M&A most-direct comp), Perella Weinberg (PWP emerging), PJT Partners (PJT Blackstone-spin + premium restructuring), Centerview (private), Greenhill (acquired Mizuho 2023); vs Bulge-Bracket Goldman (GS), Morgan Stanley (MS), JPM, BAC, C, WFC at much-larger scale with selectively-Bulge-Bracket-conflicts (proprietary-trading + underwriting + lending-relationships). FY2026 catalyst is M&A-cycle recovery + capital-markets recovery + restructuring continuity + headcount-expansion. The second deep-dive — Ken Moelis founder-CEO + global-platform + multi-decade compounder thesis — covers Ken Moelis founder-CEO positioning (most-tenured founder-CEO among-major-independent-advisory firms), global-platform build-out (~25 offices), Managing Director density (~1,000-1,200), founder-aligned-equity-compensation (~25-35%+), and selective-headcount-expansion. Multi-decade compounder thesis combines independent-advisory structural-share-gain (independent-advisory-share-of-US-M&A-fee-pool grew from ~15-20% 2010 to ~30-35% 2024 — secular-share-gain continues driven by Bulge-Bracket-conflict-concerns + elevated CEO/Board independent-advisor-preference + elevated PE-buy-side mandate volume), M&A-cycle recovery 2024-2026, Ken Moelis founder-CEO multi-decade continuity, selective adjacencies optionality (private-credit + PE advisory), ~$3.00/yr regular-dividend + frequent-special-dividends (cyclical capital-return), and Restructuring counter-cyclical-cash-flow stabilization. Capital position is net-cash, dividend-substantial-and-cyclical, opportunistic-buyback: net cash ~$0.30-0.55B (cash-rich-business-model — advisory-business is fee-and-cash-flow-heavy + no-material-capex), no credit-leverage (debt-free), non-rated mid-tier, ~$0.40-0.65B cash + undrawn revolver liquidity, FCF ~$200-400M/yr cyclical, regular dividend ~$3.00/yr (~$0.75/quarter, ~4-5% yield, ~75-100%+ trough payout, ~40-60% peak payout), special dividends ~$2-4/share frequent (Moelis cyclical-capital-return mechanism), ~$50-150M/yr opportunistic buybacks, ~75M shares broadly stable + Ken Moelis + Senior-Banker ~25-35%+ equity-alignment. At ~$60-90 per share, equity value ~$4.5-6.8B, EV ~$4.2-6.5B, ~16-30x cyclical-EPS and ~12-22x EV/EBITDA. Base case: M&A continues recovery + revenue $1.15-1.50B + EBITDA-margin ~25-29% + EPS $3.20-4.50 + regular-dividend hiked + special-dividend $2-3/share + ~12-25% return. Bull case: M&A inflects strongly + EPS $4.50-6.50 + special-dividend $3-5/share + re-rate 18-22x + 30-50%+ return. Bear case: M&A weak + EPS $1.80-2.50 + special-dividend reduced + de-rate 14-17x + flat-to-negative.